As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials
As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials
Fewer than planned beneficiaries attended the coronavirus vaccination sessions at the start due to transient technical issues in CoWIN portal and vaccine hesitancy, among others, the government said
Sources said vaccination will now begin for frontline workers too from Saturday onwards
The third phase of vaccination against the coronavirus is likely to commence in March and will cover 27 crore people aged 50 years and above and those with co-morbidities
A group of Russian experts is expected to visit Serbia next week for talks about local production of the Sputnik V vaccine by the end of the year
The government said that almost all vaccines developed through the partnership would be variants of CureVac's existing shot, which is currently undergoing late-stage clinical trials
Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December
Harsh Vardhan doesn't give exact date of third stage of rollout, says 22 countries want covid vaccines from India
The tool could quickly help develop new vaccines and zero in on the best potential preventives
The EU consists of 27 countries
Business Standard brings you top news of the evening
India's caseload has been declining in recent months
Longer-term U.S. Treasury yields rose in anticipation of a large pandemic relief bill from Washington
Gavi's vaccine commitments, wealthy countries baulk at IP waiver proposal, Covid-19 'personalities'-news relevant to India's fight against Covid-19
Johnson & Johnson seeks US FDA nod for vaccine, Gilead's Covid drug delivers $2bn boost to Q4 revenue, Beijing Winter Olympics face Covid hurdle and other pandemic-related news across the globe
Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine
Pfizer had a meeting with India's drugs regulator on Wednesday and the decision was made after that, the company said.
The total cases mounted to 1,08,02,591, while the death toll increased to 1,54,823 with 120 daily new fatalities, the data updated at 8 am showed
"A new lockdown can only be considered as a very last resort. Currently, the situation does not justify such a move," Castex told reporters at the briefing